Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lionheart Health has demonstrated the ability to control regenerative protein expressions in preclinical models and over 300 patients in pilot clinical studies. The company’s bioelectric stimulation platform has received multiple FDA 510(k) clearances for aesthetic applications. It was named a top 40 semi-finalist in the $101M XPRIZE Healthspan Competition based on its clinical data supporting muscle/cognitive/immune restoration. Ongoing IRB-approved trials are planned to further validate healthspan extension protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lionheart Health.